Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayer Fishman

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Expert Opinion on Investigational Drugs|April 1, 2003
Novel therapies for renal cell carcinoma--an updateMayer Fishman, Scott Antonia
Frontiers in Oncology|December 13, 2012
Clinical opportunities in combining immunotherapy with radiation therapySteven E Finkelstein, Mayer Fishman
Translational Andrology and Urology|January 28, 2016
Milestones for development of tivozanib for kidney cancer therapyRobert Crescentini, Shilpa Gupta, Mayer Fishman
Oncotargets and Therapy|July 28, 2011
Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatmentsShilpa Gupta, Estrella Carballido, Mayer Fishman
Expert Review of Anticancer Therapy|June 18, 2010
Expert opinion on the use of first-line sorafenib in selected metastatic renal cell carcinoma patientsJoaquim Bellmunt, Mayer Fishman, Timothy Eisen, et al.
Critical Reviews in Oncology/Hematology|April 20, 2010
Experience with sorafenib and adverse event managementJoaquim Bellmunt, Timothy Eisen, Mayer Fishman, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 13, 2007
Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancerPatrick W Sullivan, Parvez M Mulani, Mayer Fishman, et al.
Clinical Genitourinary Cancer|October 10, 2009
Surgery plus targeted therapy for renal cell carcinoma with isolated spermatic cord metastasisJose J Correa, Mayer Fishman, Shang-Tian Chuang, et al.
Research and Reports in Urology|July 29, 2024
Approaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the ClinicJonathan Chatzkel, Mayer Fishman, Brian Ramnaraign, et al.
Macromolecules|April 19, 2021
End-to-End Distance Distributions of Flexible Molecules: Frequency-Domain Fluorescence Energy Transfer Measurements and Rotational Isomeric State Model CalculationsJoseph R Lakowicz, Wieslaw Wiczk, Ignacy Gryczynski, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|April 1, 2003
Novel therapies for renal cell carcinoma--an updateMayer Fishman, Scott Antonia
Frontiers in Oncology|December 13, 2012
Clinical opportunities in combining immunotherapy with radiation therapySteven E Finkelstein, Mayer Fishman
Translational Andrology and Urology|January 28, 2016
Milestones for development of tivozanib for kidney cancer therapyRobert Crescentini, Shilpa Gupta, Mayer Fishman
Oncotargets and Therapy|July 28, 2011
Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatmentsShilpa Gupta, Estrella Carballido, Mayer Fishman
Expert Review of Anticancer Therapy|June 18, 2010
Expert opinion on the use of first-line sorafenib in selected metastatic renal cell carcinoma patientsJoaquim Bellmunt, Mayer Fishman, Timothy Eisen, et al.
Critical Reviews in Oncology/Hematology|April 20, 2010
Experience with sorafenib and adverse event managementJoaquim Bellmunt, Timothy Eisen, Mayer Fishman, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 13, 2007
Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancerPatrick W Sullivan, Parvez M Mulani, Mayer Fishman, et al.
Clinical Genitourinary Cancer|October 10, 2009
Surgery plus targeted therapy for renal cell carcinoma with isolated spermatic cord metastasisJose J Correa, Mayer Fishman, Shang-Tian Chuang, et al.
Research and Reports in Urology|July 29, 2024
Approaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the ClinicJonathan Chatzkel, Mayer Fishman, Brian Ramnaraign, et al.
Macromolecules|April 19, 2021
End-to-End Distance Distributions of Flexible Molecules: Frequency-Domain Fluorescence Energy Transfer Measurements and Rotational Isomeric State Model CalculationsJoseph R Lakowicz, Wieslaw Wiczk, Ignacy Gryczynski, et al.
Pageof 7